Literature DB >> 23710423

Dry Eye Disease: Impact on Quality of Life and Vision.

Miki Uchino1, Debra A Schaumberg.   

Abstract

Dry eye disease (DED) is a growing public health concern causing ocular discomfort, fatigue and visual disturbance that interferes with quality of life (QoL), including aspects of physical, social, psychological functioning, daily activities and workplace productivity. This paper assesses the current understanding of the impact of DED on QoL and vision. The full impact of DED on a patient's QoL is not easily quantifiable, but several methods and techniques have been evaluated to measure the decreased quality of vision from DED, and a number of questionnaires have been developed to quantify the impact of DED on various aspects of patient QoL. We summarize available evidence on the impact of DED based on a review of published literature.

Entities:  

Keywords:  Dry eye disease; Functional visual aquity; Quality of life; Quality of vision; Questionnaire

Year:  2013        PMID: 23710423      PMCID: PMC3660735          DOI: 10.1007/s40135-013-0009-1

Source DB:  PubMed          Journal:  Curr Ophthalmol Rep        ISSN: 2167-4868


  62 in total

1.  Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye.

Authors:  S Shimmura; J Shimazaki; K Tsubota
Journal:  Cornea       Date:  1999-07       Impact factor: 2.651

2.  The validity and reproducibility of a work productivity and activity impairment instrument.

Authors:  M C Reilly; A S Zbrozek; E M Dukes
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

3.  The economic burden of dry eye: a conceptual framework and preliminary assessment.

Authors:  Prabashni Reddy; Oren Grad; Krithika Rajagopalan
Journal:  Cornea       Date:  2004-11       Impact factor: 2.651

4.  Paradoxical increase of visual impairment with punctal occlusion in a patient with mild dry eye.

Authors:  Shizuka Koh; Naoyuki Maeda; Sayuri Ninomiya; Hitoshi Watanabe; Takashi Fujikado; Yasuo Tano; Yoko Hirohara; Toshifumi Mihashi
Journal:  J Cataract Refract Surg       Date:  2006-04       Impact factor: 3.351

Review 5.  Utility assessment to measure the impact of dry eye disease.

Authors:  Patricia Buchholz; Carolyn S Steeds; Lee S Stern; Daniel P Wiederkehr; John J Doyle; Laura M Katz; Francisco C Figueiredo
Journal:  Ocul Surf       Date:  2006-07       Impact factor: 5.033

6.  The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.

Authors:  Polyxane Mertzanis; Linda Abetz; Krithika Rajagopalan; Derek Espindle; Robin Chalmers; Christopher Snyder; Barbara Caffery; Timothy Edrington; Trefford Simpson; J Daniel Nelson; Carolyn Begley
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

7.  Test and symptoms in keratoconjunctivitis sicca and their correlation.

Authors:  K B Bjerrum
Journal:  Acta Ophthalmol Scand       Date:  1996-10

8.  Ocular fatigue is the major symptom of dry eye.

Authors:  I Toda; H Fujishima; K Tsubota
Journal:  Acta Ophthalmol (Copenh)       Date:  1993-06

9.  Performance and repeatability of the NEI-VFQ-25 in patients with dry eye.

Authors:  Kelly K Nichols; G Lynn Mitchell; Karla Zadnik
Journal:  Cornea       Date:  2002-08       Impact factor: 2.651

10.  Wavefront analysis of higher order aberrations in dry eye patients.

Authors:  Robert Montés-Micó; Araceli Cáliz; Jorge L Alió
Journal:  J Refract Surg       Date:  2004 May-Jun       Impact factor: 3.573

View more
  83 in total

1.  Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease.

Authors:  Ujwala S Saboo; Francisco Amparo; Tulio B Abud; Debra A Schaumberg; Reza Dana
Journal:  Ophthalmology       Date:  2015-05-20       Impact factor: 12.079

2.  Evidence for TRPA1 involvement in central neural mechanisms in a rat model of dry eye.

Authors:  A Katagiri; R Thompson; M Rahman; K Okamoto; D A Bereiter
Journal:  Neuroscience       Date:  2015-01-30       Impact factor: 3.590

3.  Impact of Dry Eye on Visual Acuity and Contrast Sensitivity: Dry Eye Assessment and Management Study.

Authors:  Loretta B Szczotka-Flynn; Maureen G Maguire; Gui-Shuang Ying; Meng C Lin; Vatinee Y Bunya; Reza Dana; Penny A Asbell
Journal:  Optom Vis Sci       Date:  2019-06       Impact factor: 1.973

Review 4.  Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease.

Authors:  Marjan Farid; Anshu Agrawal; Daniel Fremgen; Jeremiah Tao; He Chuyi; Anthony B Nesburn; Lbachir BenMohamed
Journal:  Ocul Immunol Inflamm       Date:  2014-12-23       Impact factor: 3.070

5.  Research Questions and Outcomes Prioritized by Patients With Dry Eye.

Authors:  Ian J Saldanha; Rebecca Petris; Genie Han; Kay Dickersin; Esen K Akpek
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389

Review 6.  Trachoma.

Authors:  Anthony W Solomon; Matthew J Burton; Emily W Gower; Emma M Harding-Esch; Catherine E Oldenburg; Hugh R Taylor; Lamine Traoré
Journal:  Nat Rev Dis Primers       Date:  2022-05-26       Impact factor: 52.329

7.  Maresin 1, a specialized proresolving mediator, stimulates intracellular [Ca2+ ] and secretion in conjunctival goblet cells.

Authors:  Markus V Olsen; Anne V Lyngstadaas; Jeffrey A Bair; Robin R Hodges; Tor P Utheim; Charles N Serhan; Darlene A Dartt
Journal:  J Cell Physiol       Date:  2020-06-08       Impact factor: 6.384

8.  Reliability and clinical applicability of a novel tear film imaging tool.

Authors:  Noémi Tóth; Eszter Szalai; Tibor Rák; Veronika Lillik; Attila Nagy; Adrienne Csutak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-03-29       Impact factor: 3.117

9.  The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling.

Authors:  Fang-Ming Yang; Di Fan; Xiao-Qian Yang; Feng-Hua Zhu; Mei-Juan Shao; Qian Li; Yu-Ting Liu; Ze-Min Lin; Shi-Qi Cao; Wei Tang; Shi-Jun He; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2020-08-03       Impact factor: 6.150

10.  A Single-center Retrospective Trial of a Blink-assisted Eyelid Device in Treating the Signs and Symptoms of Dry Eye.

Authors:  Thomas Chester
Journal:  Optom Vis Sci       Date:  2021-06-01       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.